About
Bourla was born in 1961 in Thessaloniki, Greece. He earned a doctorate in veterinary medicine in 1985 and a Ph.D. in the biotechnology of reproduction in 1991, both at Aristotle University of Thessaloniki. He joined Pfizer in 1993 as a veterinarian and technical director for animal health in Greece, moved to the United States in 2001, and later led the Established Products business unit and the global vaccines, oncology and consumer healthcare group. Other pharmaceutical leaders with pages on Whoo include David Ricks of Eli Lilly and Company and Robert Bradway of Amgen.
Whoo compiled this page from public sources: Pfizer third-quarter 2026 results (SEC), Pfizer 2026 proxy statement, Wikipedia. It is not affiliated with or endorsed by Albert Bourla. Are you Albert Bourla? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17. Photo: Ehbrooklyn96, CC BY-SA 4.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Chairman and Chief Executive Officer — Pfizer
January 2020 – Present | New York, New York
- Chairman of the board since January 2020; CEO since January 2019
- Held the role from January to December 2018 and became a Pfizer director in 2018
- Led the innovative pharmaceuticals business after leading the global vaccines, oncology and consumer healthcare group (2014 – 2016)
- Led the business unit after senior roles in Pfizer's animal health division
- Joined Pfizer in Greece and moved to the United States in 2001
Chief Operating Officer — Pfizer
2018
Group President, Pfizer Innovative Health — Pfizer
2016 – 2017
President and General Manager, Established Products Business Unit — Pfizer
2010 – 2013
Veterinarian and Technical Director, Animal Health — Pfizer
1993
Education
Ph.D., Biotechnology of Reproduction — Aristotle University of Thessaloniki
1991
Doctor of Veterinary Medicine — Aristotle University of Thessaloniki
1985